Release Date: 14/08/14 08:32 Summary: Resignation of Director and Appendix 3Z Price Sensitive: No Download Document 180.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%